U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07457203) titled 'Study on the Drug Interaction Between Buagafuran and Voriconazole' on Feb. 26.
Brief Summary: This study is a non-randomized, open label trial aimed at evaluating the drug interaction between Buagafuran capsules and voriconazole tablets in Chinese adult healthy participants.The research period is 7 days in total.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Drug Drug Interaction (DDI)
Intervention:
DRUG: Buagafuran
Buagafuran, oral administration 30mg, signal dose in the morning of day1 and day5
DRUG: Voriconazole
Voriconazole tablets, oral administration 400 mg BID on day3, and Voriconazole tablets ...